Form 4 for CYTK CYTOKINETICS INC
Accepted 2021-10-21 00:00:00 ET · period of report 2021-10-19 · accession 0001061983-21-000243 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-10-21 | 2021-10-19 | CYTK | Jaw Ching | CFO, SVP Fin | S - Sale | $35.73 | -35.7K | 53.1K | -40% | -$1.28M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-10-19 | S | D | 35,687 | $35.73 | 53,064 | D | — | — | (F1) Amount of securities beneficially owned following reported transaction has been adjusted by 182 shares representing shares purchased pursuant to ESPP but that have not been previously reported. Reporting persons Form 4 filed on March 09, 2021 erroneously stated that the reported 88,492 shares owned following reporting persons transaction on March 08, 2021 included 727 shares of common stock purchased pursuant to ESPP, but in fact only 545 shares of common stock purchased pursuant to ESPP were included in that 88,492 share total. (F3) Includes 804 shares of common stock purchased pursuant to the Issuers 2015 Employee Stock Purchase Plan (ESPP). |